Beyond Biotech - the podcast from Labiotech
Welcome to the official Labiotech.eu podcast - Beyond Biotech! Each week, we talk about what's happening in the world of biotech, with news and interviews with experts from companies around the world. Join us as we cover the latest news, breakthroughs and innovations shaping the life sciences industry.A new podcast episode is available every Friday. The host is Dylan Kissane.
Episodes
222 episodes
How quantum computing can accelerate drug discovery
On today’s podcast, Jean-Philip Piquemal, the chief scientific officer and co-founder of Qubit Pharmaceuticals, explains how the company’s Atlas platform is leading the way to more effective and safer drugs.00:54-01:52: The histor...
Beyond Biotech podcast 69 – improving access to cell and gene therapy
This week, our guest on the podcast is Jason C. Foster, CEO of Ori Biotech.Ori is a London, U.K. and New Jersey, U.S. based manufacturing technology company pioneering flexible process discovery with translation and scalable comme...
Beyond Biotech podcast 68 – rejuvenation with stem cells
This week, our guest on the podcast is Mark Kotter, founder of newly-created company clock.bio.clock.bio, a sister company to bit.bio, which Kotter also founded and is the CEO of, aims to extend and improve quality of life by reve...
Beyond Biotech podcast 67 – natural killer cells
This week, we speak to Artiva Biotherapeutics’ CEO, Fred Aslan, M.D. The company has demonstrated the potential for efficacy and safety with natural killer (NK) cells in two cancer clinical trials. In August, the company announce...
Beyond Biotech podcast 66 – treating rare diseases with tRNA
Compared to the smallest mRNA molecule, which is 300 nucleotides long, the largest transfer RNAs (tRNA) is less than a third of the size at 76 nucleotides. Scientists at Alltrna are harnessing the unique biology of tRN...
Beyond Biotech podcast 65 – Disease X and pandemic preparedness
Disease X, a concept shrouded in mystery, represents the unknown pathogens that could unleash future epidemics or pandemics. In the wake of recent global health crises, our understanding of the profound impact of those pandem...
Beyond Biotech podcast 64 – Precision immuno-oncology therapies
Despite the huge commercial success of PD-1 inhibitors and widespread use of checkpoint inhibitors such as anti-PD-1 or anti-CTLA4, 70 to 80% of patients still experience limited or no response to existing therapies. In response to...
Beyond Biotech podcast 63 – Tackling cancer with STRIs
This week’s podcast is sponsored by Vetter.On this week’s episode, we have a conversation with Steve Worland, CEO of eFFECTOR Therapeutics.eFFECTOR is a clinical-stage biopharmaceutical company pioneering the development of a new ...
Beyond Biotech podcast 62 – cytokine-based drugs
As September 8 is Stand Up To Cancer Day, one area of promising research lies in cytokine-based drugs, which have the potential to activate T cells against tumors. Historically, toxicity from systemic cytokine treatment has remained a challenge...
Beyond Biotech podcast 61 - Blood Cancer Awareness Month
On this week’s podcast, to recognize Blood Cancer Awareness Month, we have a conversation with Affimed's CMO, Andreas Harstrick, to talk about blood cancers, and what Affimed is doing to tackle blood cancers.One of the main challenges in...
Beyond Biotech podcast 60 – The cost of research
On this week’s podcast, we have a conversation with Dr Jack Scannell, CEO of Etheros Pharmaceuticals Corp. Scannell recently co-authored a paper on the expenses related to clinical research and the factors that underly the transla...
Beyond Biotech podcast 59 – World Lung Cancer Day
Since its inception in 2012, World Lung Cancer Day has been observed every year on August 1 in order to raise awareness of lung cancer issues and magnify the need for more lung cancer research funding.Around a quarter of a million people...
Beyond Biotech podcast 58: Pepteins
To learn about pepteins, we had a conversation with Christian Schwarz, CEO and co-founder of Numaferm. Numaferm is a German biotech company, specializing in the production of pepteins, which are an underdeveloped clas...
Beyond Biotech 57: Group B Strep
2:02 Labiotech.eu news2:51 MinervaX To recognize International Group B Strep Awareness Month in July, we had a conversation with MinervaX CEO, Per Fischer. MinervaX is a privately-held Danish biotechnology com...
Beyond Biotech podcast 56: BaseLaunch
2;00 Labiotech news3:36 BaseLaunchIn today's episode, we have a conversation with Stephan Emmerth, director business development and operations at biotech startup incubator BaseL...
Beyond Biotech podcast 55: Inflammasomes
1:54 Labiotech news3:48 NodTheraThis week, we’re talking about inflammasome inhibitors with Alan Watt, CEO of NodThera.The company recently announced it is the first to show a reduction in neuroinflammation...
Beyond Biotech 54
1:24 Labiotech news3:45 TolerogenixXTolerogenixX GmbH, a biopharmaceutical company developing personalized cellular therapies aimed at achieving sustained immune tolerance to combat organ rejection and autoimmune disease...
Beyond Biotech podcast 53: Antibody-drug conjugates
2:55 Labiotech news4:27 Mablink BioscienceOn the podcast this week, we have a conversation about antibody-drug conjugates with Pejvack Motlagh, who was recently announced as the chief medical officer at Mablink Bioscienc...
Beyond Biotech podcast 52: Antiphospholipid syndrome
2:38 Labiotech news4:23 APSFA20:59 University of MichiganJune is Antiphospholipid Syndrome (APS) Awareness Month. APS is a rare autoimmune disorder in which the body recognizes certain normal compo...
Beyond Biotech podcast 51
1:13 Labiotech news3:09 Lund Spring Symposium27:36 SapientSapientSapient is an end-to-end biomarker discovery organization dedicated to accelerating the mapping of circulating chemistries in humans thro...
Beyond Biotech podcast 50: cell and gene therapy
2:45 Labiotech news4:58 Orgenesis22:35 CellProthera38:22 Terumo Blood and Cell Technologies52:02 BioSenicThe International Society for Cell & Gene Therapy (ISCT), the global society of more than 3,000 mem...
Beyond Biotech podcast 49
1:24 Labiotech news3:40 BC PlatformsA conversation about precision medicine with Tero Silvola, CEO at BC Platforms. We also discuss the acquisition of 4Pharma.The acquisition expands BCP’s global service offering ...
Beyond Biotech podcast 48
1:18 Labiotech news3:37 BioInventBioInvent International AB, a Swedish biotech company focused on the discovery and development of novel and first-in-class immune-modulatory antibodies for cancer immunotherapy, an...